To access this element change to forms mode OFF
Grant Award View - GA65847
Understanding adverse and exceptional outcomes in high-grade serous...
GA ID:
GA65847
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2022
Value (AUD):
$868,880.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Ideas
Grant Activity:
Understanding adverse and exceptional outcomes in high-grade serous ovarian cancer
Purpose:
Most women with high-grade serous ovarian cancer (HGSC) die within five years of diagnosis, as tumours often develop chemotherapy resistance. However some patients have dramatic responses to chemotherapy and survive long-term. We will examine unique cohorts of Australian women with HGSC and analyse their tumour samples to uncover mechanisms underlying unexpected clinical responses, and use cell models to understand how genetic vulnerabilities can be exploited in the treatment of HGSC.
GO ID:
GO Title:
Ideas Grants 2019
Internal Reference ID:
GNT1186505
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA